HIV-1 CONSENSUS B VIF-4 provides an early-position consensus fragment that aids analysis of N-terminal structural landscapes within the Vif protein. Its sequence supports evaluation of foundational motifs influencing regulatory assembly. Researchers utilize it to probe interaction determinants and flexibility characteristics. The peptide assists in mapping conserved elements shaping Vif function.
CAT No: H09639
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.